Today, we announced our first multicenter clinical trial. Fifteen sites, including Mayo Clinic, MultiCare Institute for Research and Innovation, and Revive Research Institute, are currently enrolling for the PREDAPT Trial: https://t.co/1yleK2LyRh
How do we navigate #precisionmedicine? Read about Multidimensional Predictive Diagnostics: The GPS of Clinical Practice in the latest issue of the Journal of Precision Medicine: https://t.co/WyOn45jlZd #RNA#futureofdx#oncology
How did you celebrate #IWD2021? Natalie LaFranzo shared more about her role at Cofactor and what led her to #science in a panel for students and teachers, hosted by the American Chemical Society : https://t.co/w3Ynbqbjc2 #womeninscience#womeninstem
Check out this awesome interview in ConvergenceRI, featuring our collaborator, Dr. Jennifer Ribeiro, whose research study on ovarian cancer was recently published! Learn how our technology is building a better clinical approach to treating ovarian cancer: https://t.co/ETrgKJXcwB
New Data Published from Women & Infants Hospital Demonstrate Utility of Predictive Immune Modeling in Ovarian Cancer - Read the Press Release summarizing the results and methods: https://t.co/abgviMAu5V #RNA#futureofDx#precisionmedicine
New Data Published from Women & Infants Hospital Demonstrate Utility of Predictive Immune Modeling in Ovarian Cancer - Read the Press Release summarizing the results and methods: https://t.co/abgviMAu5V #RNA#futureofDx#precisionmedicine
Scientific and medical research is an investment in our future, but it's not a short term investment. Learn why we believe the future of diagnostics requires a new approach to trials, in the December issue of Clinical Researcher:
https://t.co/D2E88BAokt #precisionmedicine#RNA
Cofactor has been recognized as one of the 5 Best HealthTech Solutions Providers to Watch in 2020! Read the interview with our CEO, Jarret Glasscock, in honor of this recognition:
https://t.co/e99pxA4dtI
#RNA#futureofdx#precisionmedicine#predictivemedicine
Predictive diagnostics are an essential part of #oncology#precisionmedicine
Read an interview with Douglas Adkins featured in Oncology Central discussing the precision medicine field, it’s challenges, and novel predictive technology in oncology.
https://t.co/WrxoPgrRYq
Did you read last week's post on the Battle of the Bases?
Here, we take it one step further and discuss, "Why RNA is a better measure of a patient’s current health than DNA"
https://t.co/rqOJz0mnZC
#RNA#DNA#biomarkers#healthcare#diagnostics
Interested in what it's like to work for Cofactor in one of our business roles? Hear the experiences of our VP of Market Development in a recent ChemVoices Webinar: https://t.co/MIjJpTY2ff and find more info on our careers page: https://t.co/k1Qp1fSJ4N
Why the Precision Medicine Gap is the Biggest Threat to Healthcare and Why Predictive Diagnostics is the Key to Achieving True Precision Medicine - read the full article at DiagnosticsWorld: https://t.co/jFLpz8Qksx #RNA#precisionmedicine#healthcare
Matching patients to therapies is an integral part of closing the precision medicine gap. Why does this remain a challenge?
Learn more: https://t.co/HAJa9ZADER
#RNA#precisionmedicine#oncology#FutureofDx
We're proud to announce a collaboration that has the potential to make an impact for #oncology patients!
UCSD Partners with Cofactor Genomics to Improve Patient Outcomes in Metastatic Head and Neck Cancer
Read the full release: https://t.co/Ui14qyAyQa
#precisionmedicine#RNA
Read the latest from MedCity News on why is RNA is a better measure of a patient’s current health than DNA. Learn how we measure the dynamic immune response and capture a more comprehensive picture of what’s happening at the site of the solid tumor: https://t.co/hmKFBrOoBF
Join Cofactor's CEO, Jarret Glasscock, on September 23 for a Panel Discussion featuring immuno-oncology experts hosted by Oncology Central. Register here: https://t.co/76L5IszIF6